Editas Medicine fell 26.1% in a year. Moderna rose 7.3-fold.

Same industry

EDIT against four biotech peers, a year at 100

EDIT is down 26.1% in a year. Moderna is up 7.3 times, Biogen is up 51.6%, Amgen 42.4% and Gilead Sciences 25.3%. All four did more. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 7.3-fold rise and a 26.1% fall both read honestly.

Share this chart

EDIT −26.1%. Moderna ×7.3, Biogen +51.6%, Amgen +42.4%, Gilead Sciences +25.3%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in EDIT’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

EDIT: stories, the record and filings →